All articles by Linda Stewart – Page 5
-
NewsBacterial trial fails to demonstrate early asthma prevention - prompting rethink of 'hygiene hypothesis'
A national clinical trial has found that treating young children with an oral bacterial extract did not reduce the risk of severe wheezing and respiratory illnesses that can precede asthma, potentially prompting researchers to rethink aspects of the hygiene hypothesis.
-
NewsVaccine protects against multiple fungal infections without hurting the gut
A vaccine created to battle multiple life-threatening fungal infections is successful in achieving protective immunity in pre-clinical animal models while also maintaining the biodiversity of the gut microbiome, according to a new study.
-
NewsFaster diagnostics, deeper insights: Researchers strengthen response to Ebola outbreaks
Two studies provide important insights into the challenges of responding to outbreaks - one demonstrates how diagnostic tests can be evaluated rapidly during an outbreak; the other investigates the biological properties of the 2026 BDBV strain and whether an existing Ebola vaccine could offer cross-protection.
-
NewsCommonly used cancer drugs boost MRSA antibiotics – new research
Scientists tested five anti-cancer drugs and revealed that four of them helped penicillin-type antibiotics to kill MRSA. These drugs interfere with the bacteria’s ability to make DNA, making the bacteria more vulnerable to the antibiotics.
-
NewsResearch explores why strep throat can linger, even after treatment with antibiotics
Streptococcal sore throat can linger even after treatment, turning otherwise healthy children into carriers. Using whole genome sequencing, researchers hope to discover why.
-
NewsMpox outbreak in 2022 caused by less severe form of the virus
The strain of Mpox behind the 2022 outbreak was a weakened form of the virus, which may have helped to spread it faster, a new study reports. The findings show that the virus acquired mutations before it spread globally.
-
NewsShould adults with autoimmune rheumatic conditions receive updated COVID-19 vaccines?
Adults with autoimmune rheumatic conditions who developed COVID-19 and received booster or updated (2023-2024) COVID-19 vaccines were less likely to be hospitalized for COVID-19 compared to those who received only the initial series vaccines or who were unvaccinated.
-
NewsRiver drinking water sources may face greater antibiotic resistance risks than reservoirs, study finds
A basin-wide study of 13 drinking water sources in China’s Poyang Lake region shows that water source type can strongly shape the occurrence and spread of antibiotics, antibiotic resistance genes, and resistant bacteria.
-
NewsBiochar can act as an ‘interface engineer’ to reshape the hidden world around plant roots
A new review shows how biochar simultaneously modifies soil structure, chemistry and microbial communities in the rhizosphere, offering a framework for more precise and sustainable agricultural use.
-
NewsSuper-resolution imaging reveals details inside living cells
A new fluorescence microscopy technique that generates super-resolution images from a single camera exposure could help researchers study rapid movements within cells that are difficult to capture with existing methods.
-
NewsHigh-dose flu vaccine beneficial for older people with lung disease
The risk of being hospitalised for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials.
-
NewsFrom soil to outer space: our interview with JAM Systems Microbiology Lead Editor Janet Jansson
We get to know Janet Jansson, who has been appointed as new Lead Editor in Systems Microbiology at the Journal of Applied Microbiology.
-
NewsHaving COVID-19 is associated with lower subsequent development of type 1 diabetes among those aged under 30 years
New research shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D). Furthermore, the effect is evident only in people who did not receive the SARS-CoV-2 vaccine.
-
NewsFree webinar: Nuts, bolts and getting down to brass tacks in the expanding universe of microbiome stewardship
In a fascinating free webinar from the Microbes and Social Equity 2026 Speaker Series, Dr Robert Beiko PhD will take a step back to examine a fundamental question at the heart of microbiome stewardship: what exactly are we trying to protect, and why?
-
NewsMember Q&A: Harta Wedari on how AMI has opened up new opportunities and communities
Dr Ni Luh Putu Harta Wedari, a medical doctor and Clinical Microbiology Specialist from Bali, Indonesia reveals how engaging with AMI has expanded her international network and unveiled new opportunities.
-
NewsSmall bowel microbiome offers clues to women’s health
A new study has identified differences in the makeup and organization of the small bowel microbiome between women and men. One intriguing finding was a bacterial community containing Granulicatella, found only in women.
-
NewsKazakh researchers ID antiviral and anti-inflammatory compounds in native medicinal plants
Researchers have identified biologically active compounds with antiviral, antimicrobial, and anti-inflammatory effects in several plant species native to Kazakhstan, providing new chemical and experimental data on medicinal flora from Central Asia.
-
NewsCurious by Nature: Professor Romain Glèlè Kakaï – Can we predict the next epidemic?
Professor Romain Glèlè Kakaï believes combining traditional mathematical models with artificial intelligence will improve the accuracy of epidemic forecasting and help public health leaders respond more quickly to future cholera and malaria outbreaks.
-
NewsBlueberry’s waxy shield reveals clues to gray mold resistance
Botrytis cinerea is a broad-host-range necrotrophic fungus that causes gray mold in more than 1,000 plant species. In blueberry, it can damage flowers in the field and later emerge as fruit rot after harvest, reducing shelf life, shipment quality and market value. The disease is especially challenging because latent infections ...
-
NewsA fourth T6SS in clinical Pseudomonas aeruginosa deploys the pore-forming effector TseMt
The hospital-associated pathogen Pseudomonas aeruginosa has type VI secretion systems (T6SSs). Most reference strains encode three T6SSs, but comparative genomics has identified an additional H4-T6SS in a subset of clinical isolates.